Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

PLEGRIDY™ (peginterferon beta-1a) approved in the European Union for the treatment of multiple sclerosis
Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis.
B-07The Cognitive Health Questionnaire: Initial Psychometric Data in a Multisite Multiple Sclerosis Sample.
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
Management of children with multiple sclerosis.
[Epidemiology of multiple sclerosis in the Primosky Krai and Far East regions.]
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis.
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
In vitro modeling of central nervous system myelination and remyelination.
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS.
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.
The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry.
mfERG_LAB: Software for processing multifocal electroretinography signals.
[Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using the method of reflexology].
Multiple sclerosis treatment: current best practice.
Direct angiotensin AT2-receptor stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.

Pages